FDA Panel Gives Thumbs Up To Some Peptide Compounding

FDA Panel Gives Thumbs Up To Some Peptide Compounding An advisory panel recommended that compounding pharmacies be allowed to manufacture the drugs BPC-157, KPV, TB-500, and MOTS-c, Stat reported. The advisers will consider more compounds today. The recommendation is a win for Health Secretary Robert F. Kennedy Jr., but the FDA must still make the final approval. https://kffhealthnews.org/morning-breakout/pharma-072426/